IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q4 2023 Holdings

Filed 2024-02-14 | 12 holdings | $41.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$41.5M160,48099.4%
Exelixis Inc(EXEL)COM30161Q104$45.6K1,899,0790.1%
United Therapeutics Corp(UTHR)COM91307C102$44.2K200,8720.1%
Regeneron Pharmaceuticals(REGN)COM75886F107$41.5K47,2560.1%
Cardinal Health Inc(CAH)COM14149Y108$28.4K281,4760.1%
Taro Pharmaceutical IndusCOMM8737E108$27.0K646,4530.1%
Alkermes PLC(ALKS)COMG01767105$25.5K918,0380.1%
Jazz Pharmaceuticals PLC(JAZZ)COMG50871105$12.3K100,0000.0%
Sanofi(SNY)COM80105N105$7.5K150,4000.0%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$7.0K742,8240.0%
Masimo Corp(MASI)COM574795100$9388,0000.0%
Mural Oncology PLCCOMG63365103$53890,8330.0%